BioSpace News Archive

Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the third quarter ended September 30, 2022.

Tarsus Pharmaceuticals, Inc. today announced financial results for the third quarter ended September 30, 2022, and recent business achievements.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, today announced a poster presentation by an academic collaborator at Neuroscience 2022 by the Society for Neuroscience being held November 12-16, 2022, at the San Diego Convention Center in San Diego, Calif.

Clearside Biomedical, Inc. announced today positive results from its OASIS Phase 1/2a clinical trial of CLS-AX (axitinib injectable suspension) administered by suprachoroidal injection via Clearside’s SCS Microinjector® in neovascular age-related macular degeneration (wet AMD) patients.

SCYNEXIS, Inc. today reported financial results for the third quarter ended on September 30, 2022.

LumiraDx Limited today announced operational and financial results for the third quarter ended September 30, 2022.

Kernal Biologics, Inc. today announced it will have three presentations at the International mRNA Health Conference being held in Boston and virtually from November 8th to 10th, 2022.

ZentalisTM Pharmaceuticals, Inc. today announced financial results for the third quarter ended September 30, 2022 and highlighted recent corporate accomplishments.

Ionis Pharmaceuticals, Inc. reported financial results for the third quarter of 2022.

Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced that it will be presenting a poster on November 11 at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC).